Lipids and retroviruses

Lipids

Volumn 35, Issue 2, 2000, Pages 123-130

  Raulin, Jeanine ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LIPID; ZALCITABINE; ZIDOVUDINE;

CELL MEMBRANE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIPID ANALYSIS; RECEPTOR BINDING; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIROGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034126876     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02664760     Document Type: Review

References (77)

1. Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vésinet-Brun, F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983) Isolation of a T-lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS), Science 220, 868-871.
2. Darlix, J.-L. (1991) Eléments de Structure et de Variabilité du Rétrovirus Humain HIV-1, Bull. Inst. Pasteur 89, 211-242.
3. Aloia, R.C., Curtan, C.C., and Jensen, F.C. (1992) Membrane Cholesterol and Human Immunodeficiency Virus Infectivity, in Membrane Interactions of HIV (Aloia, R.C., and Curtain, C.C., eds.), pp. 283-303, Wiley-Liss Inc., New York.
4. Patel, R.A., and Crews, F. (1992) Membrane Lipids and Dynamics in the Enveloped Virus Life Cycle, in Membrane Interactions of HIV (Aloia, R.C., and Curtain, C.C., eds.), pp. 237-253, Wiley-Liss Inc., New York.
5. Aloia, R.C., Tian, H., and Jensen, F.C. (1993) Lipid Composition and Fluidity of the Human Immunodeficiency Virus Envelope and Host Cell Plasma Membranes, Proc. Natl Acad. Sci. USA 90, 5181-5185.
6. Prasad, K.V.S., Kapeller, R., Janssen, O., Repke, H., Duke-Cohan, J.S., Cantley, L.C., and Rudd, C.E. (1993) Phosphatidylinositol (PI) 3-Kinase and PI 4-Kinase Binding to the CD4-p56(lck) Complex: the p56(lck) SH3 Domain Binds to PI 3-Kinase but not PI 4-Kinase, Mol. Cell. Biol. 13, 7708-7717.
7. Shenoy-Scaria, A.M., Timson-Gauen, L.K., Kwong, J., Shaw, A.S., and Lublin, D.M. (1993) Palmitoylation of an Ammo-Terminal Motif of Protein Tyrosine Kinase p561ck and p59fyn Mediates Interaction with Glycosyl-Phosphatidylinositol-anchored Proteins. Mol. Cell. Biol. 13, 6385-6392.
8. Johnson, D.R., Bhatnagar, R.S., Knoll, L.J., and Gordon, J.I. (1994) Genetic and Biochemical Studies of Protein N-Myristoylation, Annu. Rev. Biochem. 63, 869-914.
9. Berthiaume, L., and Resh, M.D. (1995) Biochemical Characterization of a Palmitoyl Acyltransferase Activity that Palmitoylates Myristoylated Proteins, J. Biol. Chem. 270, 22399-22405.
10. Boutin, J.A. (1997) Myristoylation. Review, Cell. Signal. 9, 15-35.
11. Ho, Y.S., Swenson, L., Derewenda, U., Serre, L., Wei, Y., Dauter, Z., Hattori, M., Adachi, T., Aoki, J., Arai, H., Inoue, K., and Derewenda, Z.S. (1997) Brain Acetylhydrolase that Inactivates Platelet-Activating Factor Is a G-Protein-like Trimer, Nature 385, 89-93.
12. Leung, D.W., Peterson, P.K., Weeks, R., Gekker, G., Chao, C.C., Kaplan, A.H., Balantac, N., Tompkins, C., Underiner, G.E., Bursten, S., Harris, W., Bianco, J.A., and Singer, J. (1995) CT-2576, an Inhibitor of Phospholipid Signaling, Suppresses Constitutive and Induced Expression of Human Immunodeficiency Virus, Proc. Natl. Acad. Sci. USA 92, 4813-4817.
13. Yao, B., Zhang, Y., Delikat, S., Mathias, S., Basu, S., and Kolesnick, R. (1995) Phosphorylation of Raf by Ceramide-Activated Protein Kinase, Nature 378, 307-310.
14. Arenzana-Seisdedos, F., Fernandez, B., Dominguez, I., Jacqué, J.-M., Thomas, D., Diaz-Meco, M.-T., Moscat, J., and Virelizier, J.-L. (1993) Phosphatidylcholine Hydrolysis Activates NF-KB and Increases Human Immunodeficiency Virus Replication in Human Monocytes and T Lymphocytes, J. Virol. 67, 6596-6604.
15. Göttlinger, H.G., Sodroski, J.G., and Haseltine, W.A. (1989) Role of Capsid Precursor Processing and Myristoylation in Morphogenesis and Infectivity in Human Immunodeficiency Virus Type 1, Proc. Natl. Acad. Sci. USA 86, 5781-5785.
16. Bryant, M.L., and Ratner, L. (1990) Myristoylation-Dependent Replication and Assembly of Human Immunodeficiency Virus 1, Proc. Natl. Acad. Sci. USA 87, 523-527.
17. Peitzsch, R.M., and McLaughlin, S. (1993) Binding of Acylated Peptides and Fatty Acids to Phospholipid Vesicles: Pertinence to Myristoylated Proteins, Biochemistry 32, 10436-10443.
18. Pantaleo, G. (1997) Immunology of HIV Infection, Res. Immunol, (Imm. System Mol. Cell. Comp.) 148, 417-419.
19. Wahl, L.M., Corcoran, M.L, Pyle, S.W., Arthur, L.O., Harel-Bellan, A., and Farrar, W.L. (1989) Human Immunodeficiency Virus Glycoprotein (gp 120) Induction of Monocyte Arachidonic Acid Metabolites and Interleukin 1, Proc. Natl. Acad. Sci. USA 86, 621-625.
20. Hayek, M.G., Han, S.N., Wu, D.Y., Watkins, B.A., Meydani, M., Dorsey, J.L., Smith, D.E. and Meydani, S.N. (1999) Dietary Conjugated Linoleic Acid Influences the Immune Response of Young and Old C57BL/6NCrlBR Mice, J. Nutr. 129, 32-38.
21. Martinon, F., Cras-Masse, H., Boutillon, C., Chirat, F., Deprez, B., Guillet, J.-G., Gomard, E., Tartar, A., and Levy, J.-P. (1992) Immunization of Mice with Lipopeptides Bypasses the Prerequisite for Adjuvant. Immune Response of BALB/c Mice to HIV Envelope Glycoprotein, J. Immunol. 149, 3416-3422.
22. Sauzet, J.-P., Déprez, B., Martinon, F., Guillet, J.-G., GrasMasse, H., and Gomard, E. (1995) Long-Lasting Anti-Viral Cytotoxic T Lymphocytes Induced in vivo with Chimeric-Multirestricted Lipopeptides, Vaccine 13, 1339-1345.
23. Shimizu, T., Iwamoto, Y., Yanagihara, Y., Ryoyama, K., Maruyama, Y., and Achiwa, K. (1996) Antibody-Producing Effects in Mice by Synthetic Immunoreactive Lipopeptides with the Conjugated Amino Acid Sequence of gpl20 in Human Immunodeficiency Virus, Biol. Pharm. Bull. 19, 1271-1274.
24. Kucera, L.S., Piantadosi, C., and Modest, E.J. (1992) Novel Membrane Interactive Ether Lipids with Anti-Human Immunodeficiency Virus Activity, in Membrane Interactions of HIV (Aloia, R.C., and Curtain, C.C., eds.), pp. 329-350, Wiley-Liss, Inc., New York.
25. Calogeropoulou, T., Koufaki, M., Tsotinis, A., Balzarini, J., De Clercq, E., and Makriyannis, A. (1995) Synthesis and Anti-HIV Evaluation of Alkyl and Alkoxyethyl Phosphodiester AZT Derivatives, Antivir. Chem. Chemother. 6, 43-49.
26. Kucera, L.S., Iyer, N., Morrinatschke, S.L., Chen, S.Y., Gumus, F., Ishaq, K., and Herrmann, D.B.J. (1998) In vitro Evaluation and Characterization of Newly Designed Alkylamidophospholipid Analogues as Anti-Human Immunodeficiency Virus Type 1 Agents, Antivir. Chem. Chemother. 9, 157-165.
27. Krugner-Higby, L., Goff, D., Edwards, T., Iyer, N., Neufeld, J., Kute, T., Morris-Natschke, S., Ishaq, K., Piantadosi, C., and Kucera, L.S. (1995) Membrane-Interactive Phospholipids Inhibit HIV Type 1-Induced Cell Fusion and Surface gp160/gp120 Binding to Monoclonal Antibody, AIDS Res. Hum. Retrovir. 11, 705-712.
28. Wasner, M., Suhadolnik, R.J., Horvath, S.E., Adelson, M.E., Kon, N., Guan, M.-X., Henderson, E.E., and Pfleiderer, W. (1996) Synthesis and Characterization of Cordycepin-Trimervitamin and Lipid Conjugates Potential Inhibitors of HIV-1 Replication, Helv. Chim. Acta 79, 619-633.
29. Hosteller, K.Y., Kini, G.D., Beadle, J.R., Aldern, K.A., Gardner, M.F., Border, R., Kumar, R., Barshak, L., Sridhar, C.N., Wheeler, C.J., and Richman, D.D. (1996) Lipid Prodrugs of Phosphono-Acids: Greatly Enhanced Antiviral Activity of 1-O-Octadecyl-sn-Glycero-3-Phosphonoformate in HIV-1, HSV-1 and HCMV-Infected Cells, in vitro, Antivir. Res. 31, 59-67.
30. Patent Evaluation Anti-infectives (1996) Phosphonic Acid Prodrugs with Improved Antiviral Activity, University of California: WO 9615132, Exp. Opin. Ther. Patents 6, 1331-1333.
31. Kini, G.D., Hostetler, K.Y., Beadle, J.R., and Aldern, K.A. (1997) Synthesis and Antiviral Activity of 1-O-Octadecyl-2-O-Alkyl-sn-Glycero-3-Foscarnet Conjugates in Human Cytomegalovirus-Infected Cells, Antivir. Res. 36, 115-124.
32. Hostetler, K.Y., Richman, D.D., Forssen, E.A., Selk, L., Basava, R., Gardner, M.F., Parker, S., and Basava, C. (1994) Phospholipid Prodrug Inhibitors of the HIV Protease. Antiviral Activity and Pharmacokinetics in Rats, Biochem. Pharm. 48, 1399-1404.
33. Bryant, M.L., Heuckeroth, R.O., Kimata, J.T., Ratner, L., and Gordon, J.I. (1989) Replication of Human Immunodeficiency Virus 1 and Moloney Murine Leukemia Virus Is Inhibited by Different Heteroatom-Containing Analogs of Myristic Acid, Proc. Natl Acad. Sci. USA 86, 8655-8659.
34. Pidgeon, C., Markovich, R.J., Liu, M.D., Holzer, T.J., Novak, R.M., and Keyer, K.A. (1993) Antiviral Phospholipids. Anti-HIV Drugs Conjugated to the Glycerobackbone of Phospholipids, J. Biol. Chem. 268, 7773-7778.
35. Parang, K., Wiebe, L.I., Knaus, E.E., Huang, J.S., Tyrell, D.L., and Csizmadia, F. (1997) In vitro Antiviral Activities of Myristic Acid Analogs Against Human Immunodeficiency and Hepatitis B Viruses, Antivir. Res. 34, 75-90.
36. Batielli, D., Bellei, M., Arrigoni-Martelli, E., Muscatello, U., and Bobyleva, V. (1992) Interaction of Carnitine with Mitochondrial Cardiolipin, Biochim. Biophys. Acta 1117, 33-36.
37. Dalakas, M.C., Leon-Monzon, M.E., Bernardini, I., Gahl, W.A., and Jay, C.A. (1994) Zidovudine-Induced Mitochondrial Myopathy Is Associated with Muscle Carnitine Deficiency and Lipid Storage, Ann. Neurol. 35, 482-486.
38. Semino-Mora, M.C., Leon-Monzon, M.E., and Dalakas, M.C. (1994) Effect of L-Carnitine on the Zidovudine-Induced Destruction of Human Myotubes. Part I: L-Carnitine Prevents the Myotoxicily of AZT in Vitro, Lab. Invest. 71(I), 102-112.
39. Semino-Mora, M.C., Leon-Monzon, M.E., and Dalakas M.C. (1994) The Effect of L-Carnitine on the AZT-induced Destruction of Human Myotubes. Part II: Treatment with L-Carnitine Improves the AZT-Induced Changes and Prevents Further Destruction, Lab. Invest. 71, 773-781.
40. Benbrik, E., Chariot, P., Bonavaud, S., Ammi-Saïd, M., Frisdal, E., Rey, C., Gherardi, R., and Barlovatz-Meimon, G. (1997) Cellular and Mitochondrial Toxicity of Zidovudine (AZT), Didanosine (ddl) and Zalcitabine (ddC) on Cultured Human Muscle Cells, J. Neurol. Sci. 149, 19-25.
41. Düzgünes, N., Larsen, C.E., Stamatatos, L., and Konopka, K. (1992) Fusion of Immunodeficiency Viruses with Liposomes and Cells: Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by Cardiolipin Liposomes, in Membrane Interactions of HIV (Aloia, R.C., and Curtain, C.C., eds.), pp. 317-327, Wiley-Liss Inc., New York.
42. Flasher, D., Konopka, K., Chamow, S.M., Dazin, P., Ashkenazi, A., Pretzer, E., and Düzgünes, N. (1994) Liposome Targeting to Human Immunodeficiency Virus Type 1-Infected Cells via Recombinant Soluble CD4 and CD4 Immunoadhesin (CD4-IgG), Biochim. Biophys. Acta 1194, 185-196.
43. Makabi-Panzu, B., Lessard, C., Beauchamp, D., Désormeaux, A., Poulin, L., Tremblay, M., and Bergeron, M.G. (1995) Uptake and Binding of Liposomal 2′,3′-Dideoxycytidine by RAW 264.7 Cells: a Three-Step Process, J. Acq. Imm. Def. Syndr. Hum. Retrovir. 8, 227-235.
44. Nunez, E.A., and Christeff, N. (1994) Steroid Hormone, Cytokine, Lipid and Metabolic Disturbances in HIV Infection, Baillière's Clin. Endocr. Metab. 8, 803-824.
45. Keréveur, A., Cambillau, M., Kazatchkine, M., and Moatti, N. (1996) Anomalies Lipoprotéiniques au Cours de l'Infection par le VIH, Ann. Med. Int. 147, 333-343.
46. Vicenzi, E., Biswas, P., Mengozzi, M., and Poli, G. (1997) Role of Pro-inflammatory Cytokines and Beta-Chemokines in Controlling HIV Replication, J. Leukocyte Biol. 62, 34-40.
47. Skot, J., Kabrit, P., Hansen, J.-E.S., Nielsen, J.O., Nielsen, L., and Lundgren, J.D. (1994) Tumour Necrosis Factor and Eicosanoid Production from Monocytes Exposed to HIV in vitro, APMIS 102, 603-611.
48. Genis, P., Jett, M., Bernton, E.W., Boyle, T., Gelbard, H.A., Dzenko, K., Keane, R.W., Resnick, L., Mizrachi, Y., Volsky, D.J., Epstein, L.G., and Gendelman, H.E. (1992) Cytokines and Arachidonic Metabolites Produced During Human Immunodeficiency Virus (HIV)-Infected Macrophage-Astroglia Interactions: Implication for the Neuropathogenesis of HIV Disease, J. Exp. Med. 176, 1703-1718.
49. Foley, P., Kazazi, F., Biti, R., Sorrell, T.C., and Cunningham, A.L. (1992) HIV Infection of Monocytes Inhibits the T-Lymphocyte Proliferative Response to Recall Antigens, via Production of Eicosanoids, Immunology 75, 391-397.
50. Sandstrom, P.A., Tebbey, P.W., Van Cleave, S., and Buttke, T.M. (1994) Lipid Hydroperoxides Induce Apoptosis in T Cells Displaying a HIV-Associated Glutathione Peroxidase Deficiency, J. Biol. Chem. 269, 798-801.
51. Piedimonti, G., Guetard, D., Magnani, M., Corsi, D., Picerno, I., Spataro, P., Kramer, L., Montroni, M., Silvestri, G., Roca, J.F.T., and Montagnier, L. (1997) Oxidative Protein Damage and Degradation in Lymphocytes from Patients Infected with Human Immunodeficiency Virus, J. Infect. Dis. 176, 655-664.
52. Skowronski, E.W., Kolesnick, R.N., and Green, D.R. (1996) Fas-Mediated Apoptosis and Sphingomyelinase Signal Transduction: The Role of Ceramide as a Second Messenger for Apoptosis, Death Differentiation 3, 171-176.
53. Moretti, S., Alesse, E., Di Marzio, L., Zazzeroni, F., Ruggeri, B., Marcellini, S., Famularo, G., Steinberg, S.M., Boschini, A., Cifone, M.G., and De Simone, C. (1998) Effect of L-Carnitine on Human Immunodeficiency Virus-1 Infection-Associated Apoptosis: A Pilot Study, Blood 91, 3817-3824.
54. Liles, W.C. (1997) Apoptosis. Role in Infection and Inflammation (review), Curr. Op. Infect. Dis. 10, 165-170.
55. Carreau, J.-P., Lapous, D., and Raulin, J. (1977) Signification des Acides Gras Essentiels dans le Métabolisme Intermédiaire. Hypothèses sur la Synthèse de l'Acide Lipoïque, Biochimie 59, 487-496.
56. Carreau, J.-P. (1979) Biosynthesis of Lipoic Acid via Unsaturated Fatty Acids, in Methods in Enzymology (Colowick, S.P., and Kaplan, N.O., eds.). Vitamins & Coenzymes (Part D: McCormick, D.B., and Wright, L.D., eds.), pp. 152-158, Academic Press, New York.
57. Packer, L., Witt, E.H., and Tritschler, H.J. (1995) Alpha-Lipoic Acid as a Biological Antioxidant. Review Article, Free Radical Biol. Med. 19, 227-250.
58. Goureau-Counis, M.-F., Fichot, O., Raulin, J., and De Recondo, A.-M. (1974) Phospholipid Configuration and Template Capacity of Liver Nuclei and Purified Chromatin in Presence or Absence of Hepatic DNA Polymerase, Physiol. Chem. Phys. 6, 379-392
59. Launay, M., Lapous, D., and Raulin, J. (1982) Control of Replication by Dietary Lipids and Namely by Linoleic Acid in Liver and Adipose Tissue of Developing Rats, Progr. Lipid Res. 20, 331-338.
60. Xi, S., Cohen, D., and Chen, L.H. (1998) Effects of Fish Oil on Cytokines and Immune Functions of Mice with Murine AIDS, J. Lipid Res. 39, 1677-1687.
61. Okawa, A., Murate, T., Izuta, S., Takemura, M., Furuta, K., Kobayashi, J., Kamikawa, T., Nimura, Y., and Yoshida, S. (1998) Sulfated Glycoglycerolipid from Archaebacterium Inhibits Eukaryotic DNA Polymerase Alpha, Beta and Retroviral Reverse Transcriptase and Affects Methyl Methane Sulfonate Cytotoxicity, Int. J. Cancer 76, 512-518.
62. Vourc'h, C., Eychenne, B., Jo, D.-H., Raulin, J., Lapous, D., Baulieu, E.-E., and Robel, P. (1992) Delta 5-3 Beta-Hydroxysteroid Acyl Transferase Activity in the Rat Brain, Steroids 57, 210-214.
63. Moog, C., Aubertin, A.M., Kirn, A., and Luu, B. (1998) Oxysterols, but Not Cholesterol, Inhibit Human Immunodeficiency Virus Replication in vitro, Antivir. Chem. Chemother. 9, 491-496.
64. De Simone, C., Famularo, G., Cifone, G., and Mittsuya, H. (1998) HIV-1 Infection and Cellular Metabolism, Trends Immunol. Today, 17, 256-258.
65. Brogi, A., Presentini, R., Piomboni, P., Collodel, G., Strazza, M., and Constantino-Ceccarini, E. (1995) Human Sperm and Spermatogonia Express a Galactoglycerolipid Which Interacts with gp120, J. Submicr. Cytol. Pathol. 27, 565-571.
66. Brogi, A., Presentini, R., Solazzo, D., Piomboni, P., and Constantino-Ceccarini, E. (1996) Interaction of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 with a Galactoglycerolipid Associated with Human Sperm, AIDS Res. Hum. Retrovir. 12, 483-489.
67. Zhang, H., Dornadula, G., Beumont, M., Livornese, L., van Uitert, B., Henning, K., and Pomerantz, R.J. (1998) Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiviral Therapy, N. Engl. J. Med. 339, 1803-1809.
68. Lipsky, J.J. (1998) Abnormal Fat Accumulation in Patients with HIV-1 Infection, Lancet 351, 847-848.
69. Lo, J.C., Mulligan, K., Tai, V.W., Algren, H., and Schambelan, M. (1998) "Buffalo Hump" in Men with HIV-1 Infection, Lancet 351, 867-870.
70. Miller, K.D., Jones, E., Yanovski, J.A., Shankar, R., Feuerstein, I., and Falloon, J. (1998) Visceral Abdominal-Fat Accumulation Associated with Use of Indinavir, Lancet 351, 871-875.
71. Duncombe, C., Bloch, M., Austin, D., and Quan, D. (1998) Reversal of Hyperlipidemia and Lipodystrophy in Patients Switching Therapy to Nelfinavir, 12th World AIDS Conference, Genève, July 1998 (Int. Abstract Review Committee, ed.), Abstract 12287, p. 70, Marathon International, Hoorn, Holland.
72. Bonnet, E., Cuzin, L., Sailler, L., Obadia, M., Marchou, B., Caron, P., and Massip, P. (1998) Associated Lipodystrophy Metabolic Disorders Due to Protease Inhibitor-Containing Regimens, 12th World AIDS Conference, Genève, July 1998 (Int. Abstract Review Committee, ed.), Abstract 12299, p. 72, Marathon International, Hoorn, Holland.
73. Henry, K. (1998) Lipid Abnormalities Associated with the Use of Protease Inhibitors: Prevalance, Clinical Sequelae and Treatment, 12th World AIDS Conference, Genève, July 1998 (Int. Abstract Review Committee, ed.), Abstract 122319, p. 77, Marathon International, Hoorn, Holland.
74. Chang, E., Deleo, M., Liu, Y.T., Tetreault, D., and Beall, G. (1998) The Effect of Antiretroviral Protease Inhibitors (PIs) on Serum Lipids and Glucose in HIV-Infected Patients, 12th World AIDS Conference, Genève, July 1998 (Int. Abstract Review Committee, ed.), Abstract 12381, pp. 89-90, Marathon International, Hoorn, Holland.
75. Boix, V., Reus, S., Priego, M., Merino, E., Roman, F., Climent, E., and Portilla, J. (1998) Expanding the Spectrum of Protease Inhibitors-Induced Lipodystrophy, 12th World AIDS Conference, Genève, July 1998 (Int. Abstract Review Committee, ed.), Abstract 12398, p. 93, Marathon International, Hoorn, Holland.
76. Papadopoulos, A.I., Evangelopoulou, E.P., Nicolaidi, N.A., Zolatas, Z.N., Groutsis, G.T., Montsenigos, M.T., and Stergiou, S.G.D. (1998) Serum Lipids Changes in HIV-Infected Patients Under Combination Therapy Containing a Protease Inhibitor, 12th World AIDS Conference, Genève, July 1998 (Int. Abstract Review Committee, ed.), Abstract 50118, p. 1021, Marathon International, Hoom, Holland.
77. Pomerantz, R.J., and Trono, D. (1995) Genetic Therapies for HIV Infections: Promise for the Future, AIDS 9, 985-993.